CLINICAL_TRIALS trial_result · 2020-07-01

Clinical Trial Update: Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS) [Phase 1, Phase 2]

Phase 1/2 trial assessing safety and efficacy of rAAV-hRS1 for X-linked Retinoschisis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Beacon Therapeutics | Conditions: X-linked Retinoschisis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-07-01